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Background: The goal of the study was to implement sepsis bundles and examine the effect on patients
with severe sepsis or septic shock in intensive care units (ICUs).
Methods: All patients with severe sepsis or septic shock admitted to the 13-bed ICU were included. Sepsis
bundles were implemented within 24 hours after admission. The implementation of sepsis bundles was
categorized into preintervention (January to April 2010), education (July to October 2010), operational
(November to December 2010), and postintervention (January to April 2011) phases. Comparison of
bundle compliance and outcome between each phase were examined. We also found mortality pre-
dictors between preintervention and postintervention phases.
Results: There were 164 patients included in the study. Compared with the preintervention phase, the
bundle compliance of each phase (education, operation, and postintervention separately) was higher
(43.3%, 84.6%, and 79.2%, respectively, vs. 20.0%, p < 0.05), the hospital mortality was lower (10.0%, 23.1%,
and 24.5%, respectively, vs. 43.6%, p < 0.05). Under multivariate analyses, the predictors for mortality
between the preintervention and postintervention phases were: lactate at ICU (odds ratio [OR] 2.212),
urinary tract infection (OR 0.026), and postintervention (OR 0.239).
Conclusion: Implementation of modiﬁed sepsis bundles was successful in changing sepsis treatment
behavior and was associated with a substantial reduction in hospital mortality and trends of decreased
hospital expenditure. Factors improved hospital mortality, as lower lactate levels at ICU, urinary tract
infection, and postintervention. The proposed intervention is generally applicable to achieve similar
improvements.
Copyright  2013, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Severe sepsis, deﬁned as sepsis with one or more episodes of
acute organ dysfunction, may include persistent hypotension,
hypoxemia, metabolic acidosis, oliguria, thrombocytopenia, and
impaired liver function. In the United States, there are approxi-
mately 750,000 new cases of sepsis each year with a mortality rate
consistently higher than 25% for severe sepsis and up to 70% for
septic shock1,2. In Taiwan the age-standardized annual incidenceterest.
ent of Intensive Care Medi-
ang Kang City, Tainan 71044,
. Chen).
iwan Society of Geriatric Emergenrate of severe sepsis increased 1.6-fold (135 per 100,000 in 1997 to
217 per 100,000 in 2006). The proportion of patients with multi-
organ (2) dysfunction increased (11.7% in 1997 to 27.6% in 2006),
but there was little change in hospital mortality, averaging 30.8%3.
Considering the recent advances of therapeutic strategies such
as early appropriate antibiotic therapy4,5, early goal-directed ther-
apy (EGDT)6, low-dose steroid therapy7, tight glucose control8, and
lung-protective strategies9 have all been shown to be associated
with survival beneﬁts. The Surviving Sepsis Campaign (SSC)
guidelines, endorsed by many professional organizations
throughout the world, were developed as a plan to reduce severe
sepsis mortality by 25%10. The development and publication of
guidelines often do not lead to changes in clinical behavior11, and
the most effective means for achieving knowledge transfer remains
an unanswered question across all medical disciplines. Nationalcy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Sepsis Bundles in Patients with Severe Sepsis 61efforts to promote the SSC guidelines are nonexistent in most of
Asia, and are inﬂuenced by cost concerns that limit the imple-
mentation of potentially expensive bundles12.
Bundle care has been demonstrated to improve survival using
multifaceted strategies for changes in clinical behavior and quality
improvement13e15. Although some of the recommendations are
controversial, these studies suggested quality improvement efforts
based on the SSC guidelines were associated with improved out-
comes. Thus, an interdisciplinary team was needed to improve
early recognition and process of care in patients with severe sepsis
or septic shock based on SCC guidelines. The aim of the current
study was to implement a modiﬁed sepsis bundle and to examine
the effect of a continuous quality improvement (CQI) initiative on
treated patients. It was hypothesized that improved guideline
compliance would result in improved patient outcomes.
2. Materials and methods
2.1. Study design and patient selection
From January 1, 2010 to May 30, 2011, a prospective observa-
tional cohort study was conducted in a tertiary care medical center
in southern Taiwan. All patients with severe sepsis or septic shock
admitted to a 13-bed intensive care unit (ICU) via the emergency
department were included in the study. The time of transferring
such patients from the emergency department to the ICU was less
than 6 hours. The ICU staff included intensivists, respiratory ther-
apists, clinical nurse specialists, clinical dietitians, clinical phar-
macists, and residents, who provided 24-hour coverage. The
diagnostic criteria for severe sepsis or septic shock used in this
study were adapted from the deﬁnition developed by the
Consensus Panel of the American College of Chest Physicians and
the Society of Critical Care Medicine (1992)16. Severe sepsis was
deﬁned as the presence of at least two of four criteria for systemic
inﬂammatory response syndrome due to a proven or suspected site
of infection, in association with at least one of the following sepsis-
induced organ dysfunctions (Appendixes 1 and 2)16.
Modiﬁed sepsis bundles were implemented within 24 hours
after ICU admission in order to improve patient outcomes10
(Appendix 3). Sepsis bundles were divided into four phases: pre-
intervention (January to April 2010), education (July to October
2010), operational (November to December 2010), and post-
intervention (January to April 2011). During the education phases,
speciﬁc training, educational materials, and CQI initiative on phy-
sicians, nurses, and residency staff in the ICU were provided,
including: (1) conference lectures, bedside tutorials on the deﬁni-
tion of sepsis, and early recognition and treatment options
including decision-making algorithms; (2) a Chinese translation of
the SSC guidelines in poster and pocket format; (3) a checklist
focused on the early recognition and treatment of sepsis with
modiﬁed sepsis bundles; and (4) a computerized physician order
entry set to aid the completion of bundles. The operational phase
consisted of bundle delivery in the ICU setting. Physicians and
nurses used a sepsis checklist and pocket cards as daily reminders
of the processes involved in bundle delivery to the staffs in the ICU
and emergency department. The postintervention phase was used
as a long-term follow-up at the end of study. This study was
approved by Institutional Review Board of Chi Mei Medical Center.
2.2. Measurements
The following data were collected: (1) demographic and clinical
variables, including age, sex, body weight, height, and body mass
index (measured as body weight per square height in meters), use
of a ventilator, lactate levels in the emergency department and ICU,andmean blood glucose level within 24 hours of ICU admission; (2)
severity of each patient’s condition as determined by clinical nurse
specialists upon ICU admission using the Acute Physiology and
Chronic Health Evaluation (APACHE) II score, the Therapeutic
Intervention Scoring System (TISS) scores, Glasgow Coma Scale,
and the presence of acute organ dysfunction (as described in
Appendix 2); (3) primary infection sites; (4) outcomes, including
length of ICU and overall hospital stay, ICU and hospital mortality
rate and total hospital costs; and (5) bundle compliance measure-
ments, including individual bundles and all bundles. The primary
endpoint was comparison of bundle compliance, hospital mortality,
and hospital expenditure between each phase. Secondary outcome
measures included predictors for hospital mortality between the
preintervention and postintervention phases to avoid the possible
Hawthorne effect due to intervention.
2.3. Statistical analyses
Median values, interquartile ranges, and group size were used to
summarize the results for continuous variables. The differences
among groups, and survival and nonsurvival groups at hospital
discharge were examined by univariate analysis with a nonpara-
metric test and a chi-square test. A p value <0.05 was considered
statistically signiﬁcant. Predetermined variables (as all sepsis
bundles), or those signiﬁcantly associated with hospital mortality
in univariate analysis (p < 0.05), were tested for interaction with
multiple logistic regression analysis. Odds ratios (OR) and 95%
conﬁdence intervals (CI) were also calculated. Statistical analysis of
the datawas done using SPSS 13.0 forWindows (SPSS, Inc., Chicago,
IL, USA).
3. Results
There were 164 patients included in the current analysis (55 in
the preintervention phase, 30 in the education phase, 26 in the
operational phase, and 53 in the postintervention phase), and 42.1%
were female. Themedian agewas 74 years with amedian APACHE II
score, TISS score, and coma scale of 23, 27, and 9, respectively, on
the day of admission to the ICU. Median body weight was 58.0 kg,
with a median height of 1.6 m, and a median body mass index of
22.0 kg/m2. There were 41 patients (25.0%) with severe sepsis, and
123 patients (75.0%) had septic shock upon admission to the ICU.
The median number of acute organ dysfunctions per patient was
two, the most common of which were cardiovascular failure
(80.5%) and respiratory failure (46.7%). There were 125 patients
(76.2%) who required intubation with ventilator support. Addi-
tional results are shown in Table 1. The major sources of infection
were pneumonia (63.4%), urinary tract infection (UTI; 28.7%) and
intra-abdominal infection (IAI; 8.5%), as shown in Table 2. The
overall ICU and hospital mortality rates were 25.0% and 28.0%,
respectively. The median duration of ICU and hospital stays was 11
and 19 days, respectively. For all patients, median hospital cost was
8.5  1000 US dollars (USD) (Table 3). Each group had similar
baseline data, except the preintervention group had a lower lactate
level in the emergency department (2.7 mmol/L) and a higher
blood glucose level within 24 hours (178 mg/dL) as compared with
other groups. There were also some differences on multiorgan
failures between each group (hematologic, hepatic, metabolic, and
respiratory failure). The completion of sepsis bundles was gradually
higher after the education and operational phases (43.3% and
84.6%), and maintained a higher level (79.2%) even 1 year later
during the postintervention phase as compared with the pre-
intervention phase (20.0%, p < 0.05 as compared to each group),
especially in broad antibiotic agents, central venous oxygen satu-
ration (ScvO2) survey, blood sugar  150 mg/dL (all p < 0.05,
Table 1
Baseline data among different patients.
Items All (n ¼ 164) Preintervention Education Operational Postintervention p
JaneApr 2010 (n ¼ 55) JuleOct 2010 (n ¼ 30) NoveDec 2010 (n ¼ 26) Jan-Apr 2011 (n ¼ 53)
Sex (female) 69 (42.1%) 24 (43.6%) 6 (20.0%) 15 (57.7%) 24 (45.3%) 0.863
Age 74.0 (61.0e82.0) 72.0 (57.0e85.0) 68.0 (60.0e79.0) 78.0 (71.0e83.0) 77.0 (64.0e81.0) 0.115
Body weight (kg) 58.0 (48.0e65.9) 58.0 (46.0e65.0) 64.0 (55.7e70.0) 50.0 (42.0e60.0) 55.0 (47.5e65.0) 0.189
Height (m) 1.6 (1.6e1.7) 1.6 (1.6e1.7) 1.7 (1.6e1.7) 1.6 (1.5e1.7) 1.6 (1.5e1.7) 0.537
Body mass index 22.0 (19.1e24.9) 21.3 (19.9e25.5) 23.8 (20.8e25.5) 21.7 (16.7e23.9) 21.3 (18.7e24.8) 0.172
APACHE II scores 23.0 (18.0e29.0) 18.0 (15.0e24.0) 23.0 (15.0e27.0) 26.0 (20.0e29.0) 25.0 (19.0e29.0) 0.494
Glasgow Coma Scale 9.0 (6e14) 10.0 (7.0e14.0) 10.0 (6.0e15.0) 9.0 (7.0e12.0) 10.0 (6.0e14.0) 0.538
TISS scores 27.0 (23.0-34.0) 26.0 (20.0e28.0) 30.0 (21.0e36.0) 29.0 (24.0e33.0) 30.0 (23.5e33.5) 0.181
Severe sepsis 41 (25.0%) 15 (27.3%) 8 (26.7%) 6 (23.1%) 12 (22.6%) 0.578
Septic shock 123 (75.0%) 40 (72.7%) 22 (73.3%) 20 (76.9%) 41 (77.4%) 0.628
Lactate at emergency department (mmol/L) 2.6 (1.7e4.0) 1.9 (1.5e3.7) 2.8 (1.9-6.3) 2.8 (2.0e4.0) 3.0 (2.1e4.2) 0.004
Lactate at ICU (mmol/L) 2.0 (1.6e2.9) 2.0 (1.2e3.0) 2.0 (1.5e3.9) 1.9 (1.7e2.3) 2.0 (1.7-2.8) 0.609
Blood glucose level within 24 h (mg/dL) 132.0 (112.0e162.3) 178.0 (166.0-223.0) 148.0 (108.0e194.0) 118.0 (112.0e135.0) 120.0 (110.0e136.0) <0.001
No. of organ failures 2.0 (1.0e2.0) 2.0 (2.0e2.0) 1 (1.0e2.0) 1.0 (1.0e2.0) 2.0 (1.0-3.0) 0.610
Hematologic failure 21 (12.8%) 6 (10.9%) 3 (10.0%) 6 (23.1%) 12 (22.6%) 0.002
Hepatic failure 9 (5.5%) 3 (5.5%) 0 (0%) 3 (11.5%) 3 (5.7%) 0.017
Renal failure 13 (7.9%) 2 (3.6%) 5 (16.7%) 1 (3.8%) 5 (9.4%) 0.152
Metabolic failure 38 (23.2%) 9 (16.4%) 7 (23.3%) 11 (42.3%) 19 (35.8%) <0.001
Respiratory failure 76 (46.3%) 33 (60.0%) 8 (26.7%) 5 (19.2%) 30 (56.6%) <0.001
Cardiovascular failure 132 (80.5%) 41 (74.5%) 26 (86.7%) 21 (80.8%) 44 (83.0%) 0.535
Ventilator use 125 (76.2%) 54 (85.5%) 19 (63.3%) 18 (69.2%) 40 (75.5%) 0.994
Data are presented as median (interquartile range) or n (%).
APACHE ¼ Acute Physiology and Chronic Health Evaluation; ICU ¼ intensive care unit; TISS ¼ Therapeutic Intervention Scoring System.
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also had lower hospital mortality (10.0%, 23.1%, and 24.5%,
respectively), ICU stays (8, 10, and 10 days, respectively), hospital
stays (15,19, and 17 days, respectively) and total hospital cost (6.3,
8.3, and 8.5  1000 USD) when comparison with the pre-
intervention phase, as listed in Table 3. There were many factors
that contributed to hospital mortality, including preintervention
and postintervention phases (Table 5), but multivariate analyses
revealed the predictors for hospital mortality were lactate levels at
the ICU (OR 2.212; 95% CI, 1.305e3.759; p ¼ 0.003); UTI (OR, 0.026;
95% CI, 0.02e0.370; p ¼ 0.007), and postintervention (OR, 0.239;
95% CI, 0.266e0.766; p ¼ 0.028).
4. Discussion
Many factors might inﬂuence the outcome of severe sepsis in a
univariate study, including body weight, body mass index, condi-
tion severity (APACHE II, TISS, and Glasgow Coma Scale), IAI, and
ventilator use. However, only postintervention, lower lactate levels
in the ICU, and presence of a UTI were indicative of a strong
prognostic effect on survival after adjustment of confounding fac-
tors. Compliance with sepsis bundles in the ICU has been reported
to be associated with a reduction in mortality. Data from 15,022
patients at 165 sites revealed that improved bundle compliance
decreased the hospital mortality rate from 37% to 30.8% over 2Table 2
Infection source among different patients.
Items All (n ¼ 164) Preintervention
JaneApr 2010 (n ¼ 55) JuleO
Soft tissue 4 (2.4%) 2 (3.6%) 1 (3
Wound infection 7 (4.3%) 1 (1.8%) 2 (6
Pneumonia 104 (63.4%) 35 (63.6%) 18 (6
Urinary tract infection 47 (28.7%) 12 (21.8%) 9 (3
Intra-abdominal infection 14 (8.5%) 5 (9.1%) 3 (1
Central nervous system infection 6 (3.7%) 1 (1.8%) 2 (6
Bloodstream infection 15 (9.1%) 6 (10.9%) 0 (0
Infective endocarditis 1 (0.6%) 1 (1.8%) 0 (0
Data are presented as n (%).years13. A similar study in Spain with 2566 patients demonstrated
reduced mortality from 44.0% to 39.7% associated with increased
bundle compliance 1 year later14. Both studies show a pre-
intervention bundle completion rate less than 10%, which is com-
parable with the study from 150 ICUs of 16 Asian countries with a
mortality rate of 44.5%12. In our study, a better bundle compliance
(20.0%) at the preintervention phase, but a similar mortality rate of
43.6% was found. It is well known that adherence to new strategies
is best early after implementation (after a learning curve), and that
adherence decreases again after some time when no educational
refreshing measures are done. In contrast, our study disclosed that
the quality improvement effort was associated with a high bundle
completion rate (43.3% at education phase and highest at opera-
tional phase at 84.6%), and it was maintained to almost 80% even
after follow-up 1 year later at the end of the study period. Most
patients had almost 100% of the bundles initiated except blood
sugar control strategies (completion rate of 86.8%) at the post-
intervention phase, and a reduced hospital mortality was disclosed
(43.6e24.5%, p¼ 0.012). A trend of lower ICU and hospital stays, ICU
mortality, and hospital costs were also observed in the current
study. This is supported by results from the large cohort study in
Spain that found no differences in hospital or ICU admissions before
and after an educational program14. A practice improvement pro-
gram grounded in evidence-based guidelines may be responsible
for the survival beneﬁt observed in the current study. The effort onEducation Operational Post-intervention p
ct 2010 (n ¼ 30) NoveDec 2010 (n ¼ 26) Jan-Apr 2011 (n ¼ 53)
.3%) 0 (0%) 1 (1.9%) 0.765
.7%) 1 (3.8%) 3 (5.7%) 0.684
0.0%) 16 (61.5%) 35 (66.0%) 0.951
0.0%) 10 (38.5%) 17 (32.1%) 0.564
0.0%) 2 (7.7%) 4 (7.5%) 0.979
.7%) 1 (3.8%) 2 (3.8%) 0.728
%) 4 (15.4%) 5 (9.4%) 0.217
%) 0 (0%) 0 (0%) 0.574
Table 3
The outcomes among different patients.
Items All (n ¼ 164) Preintervention Education Operational Postintervention p
JaneApr 2010 (n ¼ 55) JuleOct 2010 (n ¼ 30) NoveDec 2010 (n ¼ 26) Jan-Apr 2011 (n ¼ 53)
ICU days 11.0 (6.0e16.0) 12.0 (7.0e16.0) 8.0 (6.0e11.0) 10.0 (6.0e16.0) 10.0 (6.0e15.0) 0.177
Hospital days 19.0 (13.0e34.0) 23.0 (13.0e35.0) 15.0 (13.0e32.0) 19.0 (11.0e34.0) 17.0 (11.0e36.0) 0.590
ICU mortality 41 (25.0%) 19 (34.5%) 3 (10.0%) 6 (23.1%) 13 (24.5%) 0.099
Hospital mortality 46 (28.0%) 24 (43.6%) 3 (10.0%) 6 (23.1%) 13 (24.5%) 0.012
Total hospital cost (1000 USD) 8.5 (5.3e12.5) 9.1 (6.1e12.8) 6.3 (4.4e11.3) 8.3 (2.1e10.0) 8.5 (4.1e10.8) 0.645
Data are presented as median (interquartile range) or n (%).
ICU ¼ intensive care unit; USD ¼ US dollars.
Sepsis Bundles in Patients with Severe Sepsis 63postintervention was responsible for the reduction of hospital
mortality after multivariate analysis. Applying the “plan-do-study-
act” cycle via CQI is probably the best approach to sustain the effect
of the educational program.
Lactate levels are frequently elevated in critically ill patients and
positively correlate with disease severity. It is well accepted that
elevated lactate levels are prognostic in prehospital, emergency
department, and ICU settings17,18. Additionally, lactate clearance or
lactate  2 mmol/L after resuscitation has been demonstrated to be
an independent predictor for improvedmortality19,20. Similarly, the
current study disclosed that lower lactate levels (2mmol/L) at ICU
admission is predictive of reduced mortality (OR 2.212, p ¼ 0.003).
Of note, emergency department physicians at our hospital often
transfer patients to the ICU for further resuscitation within 6 hours
as an alternative to EGDT at the emergency department; the lactate
levels measured during admission to the ICU may also reﬂect the
sufﬁciency of early sepsis resuscitation in the emergency depart-
ment. In 2001, Rivers et al6 demonstrated that EGDTupon admission
to the emergency department can signiﬁcantly reduce mortality in
patients with severe sepsis or septic shock. Considering the
achievement of ScvO2 70% in EGDT, an Australasian multicenter
study reported favorable ICU and overall hospital mortality rates of
18.8% and 23.1%, respectively, without including routine, ScvO2-
directed resuscitation21. Another recent study has also shown no
difference in mortality for patients with severe sepsis and septic
shock who were resuscitated with a protocol of lactate clearance
compared with a protocol of ScvO222. The current study performed
resuscitation with a goal to lower lactate levels at the time of ICU
admission. Furthermore, the insertion of a central venous catheter
was monitored and the survey of ScvO2 within 6 hours rather than
ScvO2 70%. For all clinical purposes, a low ScvO2 value is an
important warning sign of inadequate systemic oxygen, but it doesTable 4
The completion of sepsis bundles among different groups.




Broad antibiotics 155 (94.5%) 46 (83.6%)
Lactate survey 161 (98.2%) 52 (94.5%)
ScvO2 survey 137 (83.5%) 30 (54.5%)
Blood culture before antibiotics 163 (99.4%) 54 (98.2%)
Fluid resuscitation  20 mL/kg 162 (98.2%) 53 (96.4%)
Use vasopressor on refractory hypotension 164 (100.0%) 55 (100%)
Within 24 h
Check cortisol before steroid use 150 (91.5%) 49 (89.1%)
Low dose steroid on vasopressor use 164 (100.0%) 55 (100%)
Blood sugar  150 ( 80) mg/dL 106 (64.6%) 23 (41.8%)
Peak inspiratory pressure  35 (and plateau
pressure  30) cmH2O on ventilator
164 (100.0%) 55 (100%)
All completion 86 (52.4%) 11 (20.0%)
Data are presented as n (%).
ScvO2 ¼ central venous oxygen saturation.not provide guidance for the optimal therapeutic approach, as well
as the reason for the oxygen inadequacy. In addition, a normal or
high ScvO2 value does not rule out persistent tissue hypoxia, espe-
cially inpatientswith sepsis caused by decreased oxygen extraction.
Therefore, the ScvO2 value may not be suitable to guide resuscita-
tion in patients with severe sepsis or septic shock23.
Consistent with published literature, the leading sources of
sepsis in the current study were identiﬁed as pneumonia (63.4%),
UTI (28.7%), bloodstream infection (9.1%), and IAI (8.5%)12e
15,20,22,24,25. Levy et al13 suggested pneumonia as the source of
sepsis and predicted hospital mortality over other infections (OR,
1.37), whereas Blanco et al24 showed that UTI was associated with
lower mortality (OR, 0.1). The current results are comparable
with Blanco et al24 in that UTI as the origin of sepsis was associated
with lower mortality (OR, 0.029). In contrast, no independent as-
sociation of infection site with mortality after multivariate analysis
was identiﬁed in a recently published large trial25 (n ¼ 3588).
Variations may be explained by differences in the heterogeneous
population and early antibiotics.
SSC was a performance improvement process, rather than a
dedicated scientiﬁc evaluation of the effect of the guidelines on
clinical outcomes. Thus, results must be interpreted with caution in
regard to the clinical effect of bundle elements, or the protocol it-
self. The observation that achievement of glucose control is asso-
ciated with improved outcomes is not necessarily supported by
recently published data, although blood sugar control ( 150 mg/
dL) is still used as a therapeutic goal26. Currently, signiﬁcant dif-
ferences were observed between preintervention and post-
intervention blood sugar control (180.5 vs. 124.1 mg/dL); however,
this did not translate to any mortality beneﬁt.
The major limitation of the current study was the single center







30 (100%) 26 (100%) 53 (100%) <0.001
30 (100%) 26 (100%) 53 (100%) 0.109
30 (100%) 26 (100%) 53 (100%) <0.001
30 (100%) 26 (100%) 53 (100%) 0.574
30 (100%) 26 (100%) 53 (100%) 0.260
30 (100%) 26 (100%) 53 (100%) 1.000
29 (96.7%) 24 (92.3%) 49 (92.5%) 0.614
30 (100%) 26 (100%) 53 (100%) 1.000
14 (46.7%) 25 (96.2%) 46 (86.8%) <0.001
30 (100%) 26 (100%) 53 (100%) 1.000
13 (43.3%) 22 (84.6%) 42 (79.2%) <0.001
Table 5
The signiﬁcant predictors of hospital mortality among preintervention and postintervention groups.
Items Survivor (n ¼ 71) Nonsurvivor (n ¼ 37) p OR (95% CI) p
Body weight 55.0 (47.0e65.0) 63.5 (49.0e71.0) 0.035
APACHE II scores 21.0 (15.0e26.0) 26.0 (19.0e34.0) <0.001
TISS scores 27.0 (22.0e32.0) 33.0 (24.0e38.0) 0.012
Glasgow Coma Scale 10.0 (6.0e14.0) 6.0 (6.0e11.0) 0.003
Lactate at ICU 1.8 (1.5e2.3) 3.0 (2.0e4.2) <0.001 2.212 (1.305e3.759) 0.003
Urinary tract infection 26 (36.6%) 3 (8.1%) 0.001 0.026 (0.02e0.370) 0.007
Intra-abdominal infection 2 (2.8%) 7 (18.9%) 0.004
Ventilator use 51 (71.8%) 36 (97.3%) 0.002
Postintervention 40 (75.5%) 13 (35.1%) 0.044 0.239 (0.266e0.766) 0.028
Data are presented as median (interquartile range) or n (%).
APACHE ¼ Acute Physiology and Chronic Health Evaluation; CI ¼ conﬁdence interval; ICU ¼ intensive care unit; OR ¼ odds ratio; TISS ¼ Therapeutic Intervention Scoring
System.
S.-L. Chou et al.64amount of different parameters assessed. Because of non-
randomized characteristics as ethical constraints, the imple-
mentation of the bundle and quality indicators was at best
associatedwith amortality beneﬁt rather than being representative
of causal factors. It cannot be stated deﬁnitively that this beneﬁt was
due to some or all bundle elements, increased awareness of severe
sepsis, or other unrelated factors. There may be some intrinsic bias
between the preintervention and postintervention groups due to
the increasing knowledge and improved medical care over time. As
clinicians seek to improve treatment of patients with severe sepsis,
they may choose to implement the SSC guidelines or modiﬁed
bundles in their entirety, considering even the most conservative
conclusion from the current report is that doing so is unlikely to
cause harm. The current study did not recruit emergency depart-
ment staffs to join a complete sepsis bundles. ScvO2 as a resusci-
tation goal due to the inconvenience of continuous ScvO2 insertion
and the replacement of lactate measurement at ICUwasmonitored.
5. Conclusion
The current study demonstrates the implementation of the
Surviving Sepsis Guidelines into practice using a multifaceted
performance improvement initiative. This initiative was successful
in changing sepsis treatment behavior as evidenced by a signiﬁcant
increase in compliance with sepsis bundles. Over the duration of
the 1-year study, compliance was associated with a signiﬁcant
reduction in hospital mortality and a trend of decreased hospital
costs and stays in patients with severe sepsis and septic shock. This
intervention is generally applicable to other centers with a goal to
achieve similar improvements in patient outcomes.
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Appendix 1
Disease diagnostic criteria (entry criteria)
The diagnostic criteria for severe sepsis used in this study are
based on an adaptation of the operational deﬁnition developed by
the Consensus Panel of the American College of Chest Physicians
and the Society of Critical Care Medicine (Bone et al, 1992).
Proven infection: Objective identiﬁcation of a pathogen by one
or more methods, including culture of patient specimens, Gram
stain, tissue stain, polymerase chain reaction, or other recognized
methods.
Suspected infection: A highly suggestive clinical presentation.
Examples include pneumonia, abdominopelvic syndromes such ascholangitis, cholecystitis, and perforated viscus, and surgical
wound or other cutaneous infection, gross purulence, urosepsis, or
purpura fulminans.
Appendix 2
Disease diagnostic criteria: Presence of one or more acute organ
dysfunction
1. Cardiovascular (septic shock): Hypotension in the absence of
additional causes other than sepsis. For example, an arterial systolic
blood pressure (SBP) of 90 mmHg or a mean arterial pressure
(MAP)  65 mmHg for at least 1 hour despite adequate ﬂuid
resuscitation; or the need for vasoactive agents (dopamine 5 mg/
kg/min) to maintain SBP 90 mmHg or MAP  65 mmHg.
2. Respiratory: Acute lung injury due to sepsis associated with
serious hypoxemia. For example, PaO2/FiO2 < 250 without pneu-
monia or < 200 with pneumonia.
3. Renal: Oliguria with an average urine output < 0.5 mL/kg/h
for 4 hours despite adequate ﬂuid resuscitation; or Cr  2 mg/dL;
end-stage renal disease was excluded.
4. Hematologic: Thrombocytopenia. For example, a platelet
count < 80,000/mm3 or 50% decrease in platelet count from the
highest value recorded over the past 3 days.
5. Unexplainedmetabolic acidosis: Deﬁned by (1) pH 7.30 or
base deﬁcit  5.0 mEq/L and (2) a plasma lactate level > 3 mmol/L.
Measurement of pH or base deﬁcit and lactate level should occur
within a clinically relevant time interval such that a causal rela-
tionship exists between the measured values.




Within 6 hours after emergency department admission (resus-
citation bundle):
1. Broad-spectrum antibiotics: from the time of presentation,
broad-spectrum antibiotics administered within 1 hour of admis-
sion to the emergency department or within 3 hours at the time of
ICU admission.
2. Lactate survey: serum lactate measured within 6 hours.
3. ScvO2 survey: in the event of persistent hypotension despite
ﬂuid resuscitation (septic shock) and/or lactate> 4mmol/L (36mg/
dL), performed central venous catheter insertion and checked
central venous oxygen saturation (ScvO2) at the emergency
department or ICU within 6 hours.
4. Blood cultures before antibiotics: blood cultures obtained
prior to antibiotic administration and performed at the emergency
department or ICU within 6 hours.
Sepsis Bundles in Patients with Severe Sepsis 655. Fluid resuscitation‡20 mL/kg: in the event of hypotension
and/or lactate> 4mmol/L (36mg/dL), delivered an initialminimum
of 20 mL/kg of crystalloid (or colloid equivalent) within 6 hours.
6. Use vasopressor on refractory hypotension: applied vaso-
pressors for hypotension not responding to initial ﬂuid resuscita-
tion tomaintainmean arterial pressure (MAP)> 65mmHgwithin 6
hours.
Within 24 hours after emergency department admission
(management bundle):
7. Check cortisol before steroid use: cortisol level checked
under the suspicion of adrenal insufﬁciency before low-dose ste-
roids were administered for septic shock within 24 hours.
8. Low-dose steroid on vasopressor use: low-dose steroids
administered for septic shock in accordance with standardized
hospital policy within 24 hours.
9. Blood sugar  150(‡ 80) mg/dL: glucose control maintained
greater than the lower limit of normal ( 80 mg/dL, 4.4 mmol/L),
but 150 mg/dL (8.3 mmol/L).
10. Ventilator strategy: keep peak inspiratory pressure  35
(and plateau pressure  30) cmH2O on ventilator.
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